Soteria Biotherapeutics Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Out of Business

  • Employees
  • 19

Employees

  • Latest Deal Type
  • Out of Business

Soteria Biotherapeutics General Information

Description

Developer of next generation of switchable bispecific T-cell engagers intended to treat cancer patients with solid tumors. The company's platform provides small molecule-dependent activation of bispecific antibody therapies, enabling healthcare professionals to provide safer and more efficacious treatments through pulsatile activity and reduced side effects.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 1900 Alameda De Las Pulgas
  • Suite 250
  • San Mateo, CA 94403
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 1900 Alameda De Las Pulgas
  • Suite 250
  • San Mateo, CA 94403
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Soteria Biotherapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Out of Business 06-Jun-2025 Completed Out of Business
3. Secondary Transaction - Private 15-Jun-2021 Completed Generating Revenue
2. Early Stage VC (Series A) 17-May-2021 $42M $42M Completed Generating Revenue
1. Grant 01-Jan-2019 $300K Completed Generating Revenue
To view Soteria Biotherapeutics’s complete valuation and funding history, request access »

Soteria Biotherapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of next generation of switchable bispecific T-cell engagers intended to treat cancer patients with solid tumor
Drug Discovery
San Mateo, CA
19 As of 2022

Maastricht, Netherlands
 

Philadelphia, PA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Soteria Biotherapeutics Competitors (59)

One of Soteria Biotherapeutics’s 59 competitors is Cristal Therapeutics, a Venture Capital-Backed company based in Maastricht, Netherlands.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Cristal Therapeutics Venture Capital-Backed Maastricht, Netherlands
Geneos Therapeutics Venture Capital-Backed Philadelphia, PA
Centrose Venture Capital-Backed Madison, WI
Adaptimmune Therapeutics Formerly VC-backed Abingdon, United Kingdom
Ayala Pharmaceuticals Corporation Wilmington, DE
You’re viewing 5 of 59 competitors. Get the full list »

Soteria Biotherapeutics Patents

Soteria Biotherapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2022150792-A1 Indinavir based chemical dimerization t cell engager compositions Inactive 11-Jan-2021
WO-2022026939-A2 Single and dual targeting ligand induced t-cell engager compositions Inactive 31-Jul-2020
WO-2022026939-A3 Single and dual targeting ligand induced t-cell engager compositions Inactive 31-Jul-2020
AU-2020415451-A1 Chemically induced association and dissociation of therapeutic fc compositions and chemically induced dimerization of t cell engager with human serum albumin Inactive 23-Dec-2019
CA-3163035-A1 Chemically induced association and dissociation of therapeutic fc compositions and chemically induced dimerization of t cell engager with human serum albumin Pending 23-Dec-2019 C07K16/2803
To view Soteria Biotherapeutics’s complete patent history, request access »

Soteria Biotherapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Soteria Biotherapeutics FAQs

  • When was Soteria Biotherapeutics founded?

    Soteria Biotherapeutics was founded in 2018.

  • Where is Soteria Biotherapeutics headquartered?

    Soteria Biotherapeutics is headquartered in San Mateo, CA.

  • What is the size of Soteria Biotherapeutics?

    Soteria Biotherapeutics has 19 total employees.

  • What industry is Soteria Biotherapeutics in?

    Soteria Biotherapeutics’s primary industry is Drug Discovery.

  • Is Soteria Biotherapeutics a private or public company?

    Soteria Biotherapeutics is a Private company.

  • What is Soteria Biotherapeutics’s current revenue?

    The current revenue for Soteria Biotherapeutics is .

  • How much funding has Soteria Biotherapeutics raised over time?

    Soteria Biotherapeutics has raised $42M.

  • Who are Soteria Biotherapeutics’s competitors?

    Cristal Therapeutics, Geneos Therapeutics, Centrose, Adaptimmune Therapeutics, and Ayala Pharmaceuticals are some of the 59 competitors of Soteria Biotherapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process